logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
Showing 1 - 8 of 8 Items
Showing 1 - 8 of 8 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Conference Material
|
Poster

Evaluating task-sharing for non-communicable disease management in humanitarian settings: lessons learned from MSF’s model of care in Lebanon

Doumit M, Masri S, Beltran I, Incerti A, Ciglenecki I,  et al.
2023-06-07 • MSF Scientific Day International 2023
2023-06-07 • MSF Scientific Day International 2023
Journal Article
|
Research

Fixed dose combination drugs for cardiovascular disease in a prolonged humanitarian crisis in Lebanon: an implementation study

Ansbro É, Masri S, Prieto-Merino D, Willis R, Aoun Bahous S,  et al.
2023-01-25 • BMJ Open
2023-01-25 • BMJ Open
OBJECTIVES
This pre–post implementation study evaluated the introduction of fixed dose combination (FDC) medications for atherosclerotic cardiovascular disease (ASCVD) secondary prev...
Conference Material
|
Slide Presentation

Fixed dose combination drugs for cardiovascular disease in Lebanon

Ansbro E, Masri S, Prieto-Merino D, Bahous SA, Molfino L,  et al.
2022-05-11 • MSF Scientific Days International 2022
2022-05-11 • MSF Scientific Days International 2022
Conference Material
|
Video

Implementation of continuous glucose monitoring in a humanitarian setting

Masri S
2020-05-14 • MSF Scientific Days International 2020: Innovation
2020-05-14 • MSF Scientific Days International 2020: Innovation
Conference Material
|
Abstract

Fixed dose combination drugs for cardiovascular disease in Lebanon

Ansbro E, Masri S, Prieto-Merino D, Bahous SA, Molfino L,  et al.
2022-05-11 • MSF Scientific Days International 2022
2022-05-11 • MSF Scientific Days International 2022
INTRODUCTION
Cardiovascular disease (CVD) is the leading cause of death and disability globally, including in humanitarian contexts. Fixed-dose combination (FDC) drugs are cost-effec...
Conference Material
|
Abstract

Implementation of continuous glucose monitoring in a humanitarian setting

Masri S, Gutierrez M, Pieck AV, Botha I, Boulle P
2020-05-14 • MSF Scientific Days International 2020: Innovation
2020-05-14 • MSF Scientific Days International 2020: Innovation
INTRODUCTION
The management of diabetes in children in refugee settings brings challenges, including glucose monitoring, upon which adaptation of insulin treatment depends. Continuou...
Conference Material
|
Slide Presentation

Implementation of continuous glucose monitoring in a humanitarian setting

Masri S, Gutierrez M, Pieck AV, Botha I, Boulle P
2020-05-14 • MSF Scientific Days International 2020: Innovation
2020-05-14 • MSF Scientific Days International 2020: Innovation

Journal Article
|
Research

Implementation of fixed-dose combination therapy for secondary prevention of atherosclerotic cardiovascular disease among Syrian refugees in Lebanon: a qualitative evaluation

Murphy A, Willis R, Ansbro É, Masri S, Kabbara N,  et al.
2022-06-04 • BMC Health Services Research
2022-06-04 • BMC Health Services Research
BACKGROUND
We report findings of a qualitative evaluation of fixed-dose combination therapy for patients with established atherosclerotic cardiovascular disease (ASCVD) attending Méd...